| In this study of BI 853520 in Japanese and Taiwanese patients with advanced solid tumors, no dose-limiting toxicities were observed, and a maximum tolerated dose of 200 mg was identified. |
| Pharmacokinetic parameters support once-daily dosing and potential anti-tumor activity was demonstrated in this setting. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.